Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Invested Capital (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Return on Invested Capital data on record, last reported at 0.16% in Q3 2025.

  • For Q3 2025, Return on Invested Capital fell 7.0% year-over-year to 0.16%; the TTM value through Sep 2025 reached 0.16%, down 7.0%, while the annual FY2024 figure was 0.2%, 4.0% down from the prior year.
  • Return on Invested Capital reached 0.16% in Q3 2025 per AMPH's latest filing, down from 0.2% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.26% in Q2 2024 and bottomed at 0.01% in Q1 2021.
  • Average Return on Invested Capital over 5 years is 0.16%, with a median of 0.17% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: grew 12bps in 2022, then dropped -7bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.12% in 2021, then grew by 27bps to 0.15% in 2022, then skyrocketed by 57bps to 0.24% in 2023, then fell by -18bps to 0.19% in 2024, then fell by -16bps to 0.16% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.16% in Q3 2025, 0.2% in Q2 2025, and 0.18% in Q1 2025.